UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017825
Receipt number R000020649
Scientific Title Efficacy of tamsulosin or tadalafil for voiding disorders in I-125 prostate seed implant patients
Date of disclosure of the study information 2015/06/06
Last modified on 2022/06/11 16:38:26

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Efficacy of tamsulosin or tadalafil for voiding disorders in I-125 prostate seed implant patients

Acronym

Medications for I-125 prostate seed implant patients

Scientific Title

Efficacy of tamsulosin or tadalafil for voiding disorders in I-125 prostate seed implant patients

Scientific Title:Acronym

Medications for I-125 prostate seed implant patients

Region

Japan


Condition

Condition

prostate cancer

Classification by specialty

Urology Radiology

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

To compare efficacy of tamsulosin or tadalafil for voiding disorders in I-125 prostate seed implant patients

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

voiding parameters

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Open -no one is blinded

Control

Active

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Medicine

Interventions/Control_1

tamsulosin

Interventions/Control_2

tadalafil

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

40 years-old <=

Age-upper limit

80 years-old >=

Gender

Male

Key inclusion criteria

prostate cancer eligible for I125 seed implant

Key exclusion criteria

prostate cancer not eligible for I125 seed implant

Target sample size

120


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Ryuichi Mizuno MD

Organization

Keio university, school of medicine

Division name

Department of Urology

Zip code


Address

35 Shinanomachi, Shinjuku-ku

TEL

03-5363-3825

Email

mizunor@keio.jp


Public contact

Name of contact person

1st name
Middle name
Last name Ryuichi Mizuno MD

Organization

Keio university, school of medicine

Division name

Department of Urology

Zip code


Address

35 Shinanomachi, Shinjuku-ku

TEL

03-5363-3825

Homepage URL


Email

mizunor@keio.jp


Sponsor or person

Institute

Department of Urology, Keio university, school of medicine

Institute

Department

Personal name



Funding Source

Organization

None

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2015 Year 06 Month 06 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 05 Month 29 Day

Date of IRB

2015 Year 05 Month 29 Day

Anticipated trial start date

2015 Year 06 Month 06 Day

Last follow-up date

2024 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2015 Year 06 Month 05 Day

Last modified on

2022 Year 06 Month 11 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000020649